NASDAQ:AGIO
Agios Pharmaceuticals Stock Company Profile
$29.43
+0.400 (+1.38%)
At Close: Apr 18, 2024
Information
88 Sidney Street, 2nd Floor
Cambridge MA 02139-4169
617 649 8600
www.agios.com
Industry: Biotechnology
Sector: Healthcare
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
